Market Research

NA Molecular Point Of Care Testing (Using NAAT) Market - Industry Trends and Forecast to 2028

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 196 Pages Data Bridge Market Research September, 2022 DAABD17403921
Best Price Guarantee
Price from $3,500
Length 196 Pages
Publisher Data Bridge Market Research
Published Date September, 2022
SKU DAABD17403921

NA Molecular Point Of Care Testing (Using NAAT) Market - Industry Trends and Forecast to 2028

North America molecular point of care testing (using NAAT) market is projected to register a substantial CAGR of 12.1% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020, and the forecast period is 2021 to 2028.

Market Segmentation
North America Molecular point of care testing (using NAAT) Market, By Product (Instruments and Consumables & Reagents), Indication (Respiratory Infections Testing, Sexually Transmitted Infection (STI) Testing, Gastrointestinal Tract Infections Testing, and Others), End User (Laboratories, Hospitals, Clinics, Ambulatory Centers, Homecare, Assisted Living Facilities, and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Country (U.S. and Canada) – Industry Trends & Forecast to 2028.

Some of the significant factors contributing to the growth of the North America molecular point of care testing (using NAAT) market are:

• Increasing prevalence of chronic diseases
• Improving diagnosis-seeking rate
• Rising preference for homecare testing

Market Players

The key market players operating in the North America molecular point of care testing (using NAAT) market are listed below:

• SD Biosensor, Inc.
• Abbott
• F.Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc
• binx Health, Inc.
• Lucira
• Meridian Bioscience
• Quantumdx Group Ltd.
• BD
• Biomérieux Sa
• Qiagen
• Quidel Corporation
• Sysmex Corporation
• Bio-Rad Laboratories, Inc.
• Sekisui Diagnostic
• Randox Laboratories Ltd.
• GenMark Diagnostics
• Seegene Inc.
• Grifols S.A.
• Wondfo
• Oxford Nanopore Diagnostic
• PerkinElmer Inc.


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Molecular Point Of Care Testing (Using Naat) Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Primary Interviews With Key Opinion Leaders
2.7 Multivariate Modelling
2.8 Distribution Channel Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Market End User Coverage Grid
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porters Five Forces
4.2 Pestel Analysis
4.3 Annual Test Volume: For All Countries
4.3.1 Cepheid
4.3.2 Thermo Fisher Scientific Inc.
4.3.3 Hologic, Inc.
4.3.4 Bd
4.3.5 F. Hoffmann-la Roche Ltd
4.4 Number Of Poct Instruments Installed In Each Country
4.5 Distributors
4.5.1 North America
4.5.2 Europe
4.5.3 South Asia
4.5.4 South East Asia
4.5.5 Middle East
4.5.6 Africa
5 Regulatory Framework
6 Market Overview
6.1 Drivers
6.1.1 Increasing Prevalence Of Chronic Diseases
6.1.2 Improving Diagnosis Seeking Rate
6.1.3 Rising Technological Advancements
6.1.4 Rising Geriatric Population Across Globe
6.1.5 Rising Preference For Homecare Testing
6.2 Restraints
6.2.1 Product Recalls
6.2.2 High Costs Of Products
6.2.3 Non-availability Of Relevant And Appropriate Kits
6.3 Opportunities
6.3.1 Strategic Initiatives Taken By Market Players
6.3.2 Rising Healthcare Expenditure
6.3.3 Pandemic Outbreak Of Covid-19
6.3.4 Growing Demand For Better Quality Healthcare And Early Diagnosis
6.4 Challenges
6.4.1 Lack Of Alignment With Test Results Obtained From Laboratories
6.4.2 Lack Of Accessibility
7 Impact Of Covid-19 On The North America Molecular Point Of Care Testing (Using Naat) Market
7.1 Impact On Price
7.2 Impact On Demand
7.3 Impact On Supply Chain
7.4 Key Initiatives By Market Players During The Covid 19
7.5 Conclusion:
8 North America Molecular Point Of Care Testing (Using Naat) Market, By Product
8.1 Overview
8.2 Consumables & Reagents
8.3 Instruments
8.3.1 Mobile Platform (Small & Portable)
8.3.2 Facility-based Platforms (Large Poct Platform)
9 North America Molecular Point Of Care Testing (Using Naat) Market, By Indication
9.1 Overview
9.2 Respiratory Infections Testing
9.2.1 Covid-19
9.2.2 Flu B
9.2.3 Flu A
9.2.4 Rsv
9.2.5 Tuberculosis
9.2.6 Pneumonia (Pneumococcal Pneumonia)
9.2.7 Others
9.3 Sexually Transmitted Infection (Sti) Testing
9.3.1 Tv
9.3.2 Ct
9.3.3 Ng
9.3.4 Hpv
9.3.5 Hsv
9.3.6 Mg
9.3.7 Uu
9.3.8 Mh
9.3.9 Others
9.4 Gastrointestinal Tract Infections Testing
9.4.1 Group B Streptococcus
9.4.2 Shiga Toxin
9.4.3 H. Pylori
9.5 Others
10 North America Molecular Point Of Care Testing (Using Naat) Market, By End User
10.1 Overview
10.2 Laboratories
10.2.1 Polymerase Chain Reaction
10.2.2 Isothermal Amplification
10.3 Hospital
10.3.1 Polymerase Chain Reaction
10.3.2 Isothermal Amplification
10.4 Clinics
10.4.1 Polymerase Chain Reaction
10.4.2 Isothermal Amplification
10.5 Ambulatory Center
10.5.1 Polymerase Chain Reaction
10.5.2 Isothermal Amplification
10.6 Homecare
10.6.1 Polymerase Chain Reaction
10.6.2 Isothermal Amplification
10.7 Assisted Living Facilities
10.7.1 Polymerase Chain Reaction
10.7.2 Isothermal Amplification
10.8 Others
11 North America Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing
11.1 Overview
11.2 Prescription-based Testing
11.3 Otc Testing
12 North America Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel
12.1 Overview
12.2 Hospital Pharmacy
12.3 Retail Pharmacy
12.4 Online Pharmacy
13 North America Molecular Point Of Care Testing (Using Naat) Market, By Region
13.1 North America
13.1.1 U.S.
13.1.2 Canada
14 North America Molecular Point Of Care Testing (Using Naat) Market: Company Landscape
14.1 Company Share Analysis: North America
15 Swot Analysis
16 Company Profile
16.1 Danaher
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Developments
16.2 Thermo Fisher Scientific Inc.
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Developments
16.3 Bd
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Developments
16.4 F.Hoffmann-la-roche Ltd.
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Developments
16.5 Abbott
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Product Portfolio
16.5.4 Recent Developments
16.6 Binx Health, Inc.
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Development
16.7 Biomerieux Sa
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Product Portfolio
16.7.4 Recent Development
16.8 Co-diagnostics, Inc.
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Developments
16.9 Genmark Diagnostics, Inc
16.9.1 Company Snapshot
16.9.2 Revenue Analysis
16.9.3 Product Portfolio
16.9.4 Recent Development
16.10 Grifols, S.A.
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Product Portfolio
16.10.4 Recent Development
16.11 Lucira Health Inc.
16.11.1 Company Snapshot
16.11.2 Product Portfolio
16.11.3 Recent Developments
16.12 Meridian Bioscience
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Product Portfolio
16.12.4 Recent Developments
16.13 Quantumdx Group Ltd.
16.13.1 Company Snapshot
16.13.2 Product Portfolio
16.13.3 Recent Developments
16.14 Quidel Corporation
16.14.1 Company Snapshot
16.14.2 Revenue Analysis
16.14.3 Product Portfolio
16.14.4 Recent Development
16.15 Sd Biosensor, Inc.
16.15.1 Company Snapshot
16.15.2 Product Portfolio
16.15.3 Recent Development
16.16 Sekisui Diagnostics (A Subsidiary Of Sekisui Medical)
16.16.1 Company Snapshot
16.16.2 Product Portfolio
16.16.3 Recent Development
16.17 Sysmex (A Subsidiary Of Sysmex Corporation
16.17.1 Company Snapshot
16.17.2 Revenue Analysis
16.17.3 Product Portfolio
16.17.4 Recent Development
16.18 Wondfo
16.18.1 Company Snapshot
16.18.2 Product Portfolio
16.18.3 Recent Development
17 Questionnaire
18 Related Reports 196
List Of Tables
Table 1 Cepheid: Annual Test Volume, For All Countries, 2020 (Units)
Table 2 Thermo Fisher Scientific Inc. : Annual Test Volume, For All Countries, 2020 (Units)
Table 3 Hologic, Inc. : Annual Test Volume, For All Countries, 2020 (Units)
Table 4 Bd : Annual Test Volume, For All Countries, 2020 (Units)
Table 5 F. Hoffmann-la Roche Ltd : Annual Test Volume, For All Countries, 2020 (Units)
Table 6 Number Of Poct Instruments Installed In Each Country, 2020 (Units)
Table 7 Distributors Across North America
Table 8 Distributors Across Europe
Table 9 Distributors Across South Asia
Table 10 Distributors Across South East Asia
Table 11 Distributors Across Middle East
Table 12 Distributors Across Africa
Table 13 North America Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 14 North America Consumables & Reagents In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 15 North America Instruments In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 16 North America Instruments In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 17 North America Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 18 North America Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 19 North America Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 20 North America Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 21 North America Sexually Transmitted In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 22 North America Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 23 North America Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 24 North America Others In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 25 North America Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 26 North America Laborotories In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 27 North America Laborotories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 28 North America Hospital In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 29 North America Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 30 North America Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 31 North America Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 32 North America Ambulatory Center In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 33 North America Ambulatory Center In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 34 North America Home Care In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 35 North America Home Care In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 36 North America Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 37 North America Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 38 North America Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 39 North America Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 40 North America Prescription-based Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region 2019-2028 (Usd Million)
Table 41 North America Otc Testing In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 42 North America Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 43 North America Hospital Pharmacy In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 44 North America Retail Pharmacy In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 45 North America Online Pharmacy In Molecular Point Of Care Testing (Using Naat) Market, By Region, 2019-2028 (Usd Million)
Table 46 North America Molecular Point Of Care Testing (Using Naat) Market, By Country, 2019-2028 (Usd Million)
Table 47 North America Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 48 North America Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 49 North America Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 50 North America Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 51 North America Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 52 North America Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, Indication, 2019-2028 (Usd Million)
Table 53 North America Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 54 North America Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 55 North America Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 56 North America Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 57 North America Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 58 North America Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 59 North America Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 60 North America Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 61 North America Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 62 U.S. Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 63 U.S. Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 64 U.S. Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 65 U.S. Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 66 U.S. Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 67 U.S. Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, Indication, 2019-2028 (Usd Million)
Table 68 U.S. Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 69 U.S. Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 70 U.S. Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 71 U.S. Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 72 U.S. Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 73 U.S. Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 74 U.S. Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 75 U.S. Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 76 U.S. Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 77 Canada Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 78 Canada Instrument In Molecular Point Of Care Testing (Using Naat) Market, By Product, 2019-2028 (Usd Million)
Table 79 Canada Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 80 Canada Respiratory Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 81 Canada Sexually Transmitted Infection (Sti) Testing In Molecular Point Of Care Testing (Using Naat) Market, By Indication, 2019-2028 (Usd Million)
Table 82 Canada Gastrointestinal Tract Infections Testing In Molecular Point Of Care Testing (Using Naat) Market, Indication, 2019-2028 (Usd Million)
Table 83 Canada Molecular Point Of Care Testing (Using Naat) Market, By End User, 2019-2028 (Usd Million)
Table 84 Canada Laboratories In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 85 Canada Hospitals In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 86 Canada Clinics In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 87 Canada Ambulatory Centers In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 88 Canada Homecare In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 89 Canada Assisted Living Facilities In Molecular Point Of Care Testing (Using Naat) Market, By Technology, 2019-2028 (Usd Million)
Table 90 Canada Molecular Point Of Care Testing (Using Naat) Market, By Mode Of Testing, 2019-2028 (Usd Million)
Table 91 Canada Molecular Point Of Care Testing (Using Naat) Market, By Distribution Channel, 2019-2028 (Usd Million)
List Of Figures
Figure 1 North America Molecular Point Of Care Testing (Using Naat) Market: Segmentation
Figure 2 North America Molecular Point Of Care Testing (Using Naat) Market: Data Triangulation
Figure 3 North America Molecular Point Of Care Testing (Using Naat) Market: Droc Analysis
Figure 4 North America Molecular Point Of Care Testing (Using Naat) Market: North America Vs Regional Market Analysis
Figure 5 North America Molecular Point Of Care Testing (Using Naat) Market: Company Research Analysis
Figure 6 North America Molecular Point Of Care Testing (Using Naat) Market: Interview Demographics
Figure 7 North America Molecular Point Of Care Testing (Using Naat) Market: Multivariate Modelling
Figure 8 North America Molecular Point Of Care Testing (Using Naat) Market: Dbmr Market Position Grid
Figure 9 North America Molecular Point Of Care Testing (Using Naat) Market: Vendor Share Analysis
Figure 10 North America Molecular Point Of Care Testing (Using Naat) Market: End User Overage Grid
Figure 11 North America Molecular Point Of Care Testing (Using Naat) Market: Segmentation
Figure 12 North America Is Expected To Dominate The North America Molecular Point Of Care Testing (Using Naat) Market And Is Expected To Grow With The Highest Cagr In The Forecast Period
Figure 13 Increasing Prevalence Of Chronic Disease And Improving Diagnosis-seeking Rate Are Expected To Drive The North America Molecular Point Of Care Testing (Using Naat) Market In The Forecast Period
Figure 14 Consumables And Reagents Segment Is Expected To Account For The Largest Share Of The North America Molecular Point Of Care Testing (Using Naat) Market In 2021 & 2028
Figure 15 Drivers, Restraints, Opportunities, And Challenges Of North America Molecular Point Of Care Testing (Using Naat) Market
Figure 16 Medical Device Spending Vs National Health Expenditures, 2016
Figure 17 North America Molecular Point Of Care Testing (Using Naat) Market: By Product, 2020
Figure 18 North America Molecular Point Of Care Testing (Using Naat) Market: By Product, 2021-2028 (Usd Million)
Figure 19 North America Molecular Point Of Care Testing (Using Naat) Market: By Product, Cagr (2021-2028)
Figure 20 North America Molecular Point Of Care Testing (Using Naat) Market: By Product, Lifeline Curve
Figure 21 North America Molecular Point Of Care Testing (Using Naat) Market: By Indication, 2020
Figure 22 North America Molecular Point Of Care Testing (Using Naat) Market: By Indication, 2021-2028 (Usd Million)
Figure 23 North America Molecular Point Of Care Testing (Using Naat) Market: By Indication, Cagr (2021-2028)
Figure 24 North America Molecular Point Of Care Testing (Using Naat) Market: By Indication, Lifeline Curve
Figure 25 North America Molecular Point Of Care Testing (Using Naat) Market: By End User, 2020
Figure 26 North America Molecular Point Of Care Testing (Using Naat) Market: By End User, 2021-2028 (Usd Million)
Figure 27 North America Molecular Point Of Care Testing (Using Naat) Market: By End User, Cagr (2021-2028)
Figure 28 North America Molecular Point Of Care Testing (Using Naat) Market: By End User, Lifeline Curve
Figure 29 North America Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, 2020
Figure 30 North America Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, 2021-2028 (Usd Million)
Figure 31 North America Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, Cagr (2021-2028)
Figure 32 North America Molecular Point Of Care Testing (Using Naat) Market: By Mode Of Testing, Lifeline Curve
Figure 33 North America Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, 2020
Figure 34 North America Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, 2021-2028 (Usd Million)
Figure 35 North America Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, Cagr (2021-2028)
Figure 36 North America Molecular Point Of Care Testing (Using Naat)Market: By Distribution Channel, Lifeline Curve
Figure 37 North America Molecular Point Of Care Testing (Using Naat) Market: Snapshot (2020)
Figure 38 North America Molecular Point Of Care Testing (Using Naat) Market: By Country (2020)
Figure 39 North America Molecular Point Of Care Testing (Using Naat) Market: By Country (2021 & 2028)
Figure 40 North America Molecular Point Of Care Testing (Using Naat) Market: By Country (2020 & 2028)
Figure 41 North America Molecular Point Of Care Testing (Using Naat) Market: By Product (2021-2028)
Figure 42 North America Molecular Point Of Care Testing (Using Naat) Market: Company Share 2020 (%)

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings